175Yb-labeled hydroxyapatite: a potential agent for use in radiation synovectomy of small joints
- 1 May 2006
- journal article
- Published by Elsevier in Nuclear Medicine and Biology
- Vol. 33 (4) , 585-591
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Clinical efficacy of radiation synovectomy in digital joint osteoarthritisEuropean Journal of Nuclear Medicine and Molecular Imaging, 2004
- 175Yb labeled polyaminophosphonates as potential agents for bone pain palliationApplied Radiation and Isotopes, 2004
- Advances in Radionuclide Therapeutics in OrthopaedicsJournal of the American Academy of Orthopaedic Surgeons, 2004
- 188Re-tin-colloid as a new therapeutic agent for rheumatoid arthritisNuclear Medicine Communications, 2003
- Preparation and bioevaluation of 166 Ho labelled hydroxyapatite (HA) particles for radiosynovectomyNuclear Medicine and Biology, 2002
- Physical and biological dosimetry in patients undergoing radiosynoviorthesis with erbium-169 and rhenium-186Nuclear Medicine Communications, 2001
- Bifunctional Chelators for Therapeutic Lanthanide RadiopharmaceuticalsBioconjugate Chemistry, 2000
- Radiosynovectomy's clinical applications and cost effectiveness: A reviewSeminars in Nuclear Medicine, 1997
- Radiation synovectomy revisitedEuropean Journal of Nuclear Medicine and Molecular Imaging, 1993
- Thermodynamic study of lanthanide complexes of 1,4,7-triazacyclononane-N,N',N"-triacetic acid and 1,4,7,10-tetraazacyclododecane-N,N',N",N'''-tetraacetic acidInorganic Chemistry, 1987